David, us revenues thanks you, for of of and Thank everyone We for the today. third $X.X XXXX. achieved to quarter million joining
do notably, in the Dental offices the underlying sales anesthesia improvements these STA, increased domestic tooth for United true results shipping Dental our due hand store to Most the early to States. Dental single success business. by the reflect pieces directly not groups XX% selling However, new online within system, and and of and the
from strategy. of and away former validation in thus notably, We has in of resulted the XXXX. for increase Schein direct third the selling quarter important achieved moving results distributor, Henry model these an an profit our our while Even gross more new
for year. new fact, and year a margins quarter XX% the shows this increased for achieved our team, In from third business to which the third profit growth of despite last small our model. potential in We quarter our XX% gross of margins the domestic revenue sales
with our sales more a for on time streamlined the And is could to profitability bring we structure. spend being representatives, maximizing more while operating on focus
In allowing dentists addition with closer better us and job relationship provided to strategy a customers, service. margins, and customer selling our has a direct stickiness increasing to with this our the thereby us do higher improving more
being existing developing the purchase based customer activities. execution, now patterns, new words, acquisition, customer dormant or customers, we sleeping and identification upselling on the sales basic principles customers obtained and up so-called waking of other In can on focus
patients do direct-to-consumer activities engaged in have to we so. to requested our have order leads time, directly resulted more same the marketing. contacting dentists, in because from At These us instruments them
dedicated our patients. increase We marketing continue efforts directly at to campaigns with will targeted
deepen our expanding traction, and international markets. new international are domestic within markets our to we enter the efforts existing Given penetration
remains declined, sales the important Nevertheless, be we resume size growth. that international international of the sales lumpy timing pipeline our to from the orders. and note it's our and distributors third-party due orders solid, to to can expect While international
the support the of coming addition our Dental new partners, to also strategy We that also over should division to expansion which operate international global forward quarters. noting worth continues profitably. look announcing our It's
the generated increase last which fact, In Dental income same over a $XXX,XXX stand-alone period operating of a is year. XX% the division basis, on over
we to aim sales Dental at in we coming strategy, the grow with the increased marketing summarize, new that through in our business attractive to believe So margins combination our further quarters. efforts,
as as As our from economies we and well revenues, nature high recurring benefit continue to margins grow we expect the of on to our scale disposables.
division. Medical our to Turning
We have out significant our progress rolling Epidural CompuFlo made System.
of Specifically, new and the adoption hospital technology distributor CompuFlo system a added prominent a we management expanded pain and clinics. in have
and interventional end, an technology CompuFlo Brooklyn, by into this this physician. sales Epidural we in York. Towards of the by Ambulatory Island Medical commenced Leon Dr. follows Adoption Director, pain founder Center disposables of Reyfman, New a successful process Surgery its medicine evaluation clinic
to of X,XXX of addressable success. in they Reyfman than Sales market, was reported which a of completed team centers Ambulatory X represent XX the Epidural CompuFlo System in market more surgery an Surgery the the company's across Island foray center one XXX% cases ambulatory using first doctors Center Dr. who the U.S.
procedures thoracic within Epidural junction The thoracic the cervical selection lumbar, of the and spine. evaluation included
the a now implantation stimulator with system expand major procedures. beyond CompuFlo with working spinal delivery use to closely include of cord use are and we labor neurostimulation Additionally, to hospital
to performing System has in tremendous cases. stimulator proven of The CompuFlo Epidural assistance cord spinal be
to cerebral leakage well postoperative steroid as fluid and Specifically, helps underlying Cerebral postoperative stimulator postoperative extended to of and complications a admission CompuFlo this procedure. as complication routes. nerve a that block require include potential intraoperative cases radiculitis patch leakage requires spinal cord as complications trauma injections of postoperative minimize implementation. fluid These
XX decreased for the also procedure minutes time feedback. XX It clinician's surgery the to around operative per according has by to
our secure the CompuFlo growth As coverage for epidural goal to perform on is and for as anesthesiologists more a continue and we establishing more System as in care goal and reimbursement, our of submit physicians standard Epidural of technology to execute analgesia. procedures our
patients payers for were During an reimbursement motor we quarter, commercial in who the milestone, third accidents. from involved reported vehicle important
are this on continued and success advancing strategy. We making reimbursement building progress our now
we clinicians' of cases, Specifically, System support a the is of of CompuFlo reimbursement the building across utilization use level insurance appropriate for are which Epidural variety supporting from providers.
discuss These and to physicians payers, our the like reported really activities and this claims for a feedback are strategy outlook our as understanding the critical on overall by I'd of moment is their reimbursement have providers. back our from to in insurance encouraged more strategy now the business. detail take to Medical we
X areas related reimbursement. One, made in Significant of CompuFlo. provider to utilization been important progress has
processing. Secondly, claims and new by least, not CompuFlo submissions systems last CPT for code payer CompuFlo but the acceptance care for claim health of
of respective sites code of the XX payers injection, injections. date, demonstrating have technology identify important submitted use epidural primary code CompuFlo We total used the are for actively claims claims to an called procedure To their widespread U.S. across with utilizing steroid a the tracking and advisory epidural that CPT of using when the technology. primary our submitting steroid in also CompuFlo to code, to utilization payers established physicians the This is country. across have
CPT with this codes. code used If Association epidural to you of assigned conjunction as steroid the recall, be one the our existing an code, in Medical American code X add-on injection
country. end our payers submitted before the of of the claims to over target meet We projection to year across are the on XXX
being well payers. are Claims Medicare to submitted as commercial as
some motor submissions patients. previously, for as reported commercial accident paid it. responded claims to And have claims submitted Additionally, payers clinicians for and we vehicle have X these
journey for systems for technologies. claim appear CompuFlo, claims claim care and the submission health will that commercialization drive to is code code code of positive and recognition into step by codes the not to important payer new Epidural by because recognized. The along the versus emerging encouraged of designed processing Category positive III reimbursement for and loaded utilization a systems CompuFlo System. further providers their I'm is have an Category are tracking which code of rejection ours III payers our of accepted the the our like is the
on the from of as claims payers. have activities very beginning Our of report I'm advisory There mix and been their is exactly physicians report responses, anticipated. happy to wide a that are to range responses back
payers are them. Others because covering their is are based established to on CompuFlo about the new more policies. the it for of Some information asking
through have been there While payer's individual as payment denied appealed for process. claims each reported appeals part Denials denials are expected being a code. are rest utilization assured, all and new establishing of
is engage sites technology level activity by advisory Moreover, payers to with educate unmet to opportunity is technology on CompuFlo serves. of directly providing our the the high need patient and an being that the them generated claim the
claims in plan to by original So our submissions, deliver utilization claims reimbursement by XXX supporting we to over our summarize advisory target be are our clinicians to on to drive with submitted year-end. expected progress, on
providing are each for support have an individual to appropriate Additionally, claim we response.
utilization opportunity the provides to Finally, to with the Milestone increase engage CompuFlo educate on directly them technology. in payers
to front. the Turning international
Spain partners us forward in look in Most and people number We to premier near year network announcing our are epidural of of we important excess CompuFlo. of million anesthesiology. recently, an in and the in we for pain XX which appointed population distributor growing for market represents Spain, expanding a each the with distribution procedures term. management a
as look medical targeting are forward global records territories. announcing markets their and relationships international within devices commercial distributors proven with key we advance we rollout. our introducing existing independent Overall, We track additional to distributors within
is We government as there Instrument CompuFlo improved federal our opportunity our and as to patient within can market both other outcomes agencies believe efficiencies. as well also a increased contribute for Epidural system
initiatives system. working of believe secure a past, not FSS we As this when. markets. FSS, this the mind, if, it's goal our point, approval we question are approval in within following government With and it's the we advancing are supply on up DoD and open federal the a in down have markets. sizable SAM doubling discussed efforts to question approval At would penetrate government we of to the
at companies bring the ours and they was present technologies to the were U.S. Department last of Hospitals. that invited Health week of International to Ukrainian took Ministry an invited in event by The with initiative We Ukraine. place new which collaborate Kyiv Healthcare Summit, the in Defense recently like which
the the conduct would which by trials We Ukraine funded are using be advancing whereby our technology, these we DoD. the initiatives with DoD in could
opportunity ideal fortify would an our the safety addition work, In DoD highlighting with the of to this our relationship aspects by technology. our of and to efficiency believe we be the humanitarian
efforts technology are goal with into among effective we key Instrument which So our to pain to our market the remain seed summarize, translate adoption. of in to Epidural epidural complications. establishing ultimately of anesthesia of physicians, We relief the CompuFlo patients believe the risk will while the providing new standard as committed care with we continuing our by widespread reducing
Keisha to Controller, over the go over this point, Keisha. ahead, to call Harcum, I'd to At detail. like Please turn the financials in go